Medicare Enrolled
Dr. Iftikhar Khan, M.D.
Neurocritical Care Physician · Saginaw, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Iftikhar Khan is a neurocritical care physician in Saginaw, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 1,728 Medicare services across 1,416 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $4,002 from 36 pharmaceutical and/or device companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurocritical care physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in MI
$4,002 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,728
Medicare services
Top 10% in MI for neurocritical care physician
1,416
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
368 | $33 | $92 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
203 | $60 | $125 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
122 | $61 | $140 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
119 | $98 | $190 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
110 | $54 | $110 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
92 | $29 | $121 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
90 | $42 | $115 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
82 | $91 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
70 | $80 | $160 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
62 | $93 | $265 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
55 | $88 | $245 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
55 | $74 | $213 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
52 | $37 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
48 | $114 | $232 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
44 | $31 | $59 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
40 | $51 | $160 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
39 | $71 | $152 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
26 | $137 | $374 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
23 | $37 | $111 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
15 | $92 | $146 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
13 | $87 | $145 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,002
Total received (2018-2024)
Avg $667/year across 6 years
Top 44% in MI for neurocritical care physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
287
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,513 (87.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$250 (6.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$239 (6.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$284
2023
$270
2022
$104
2021
$169
2019
$914
2018
$2,260
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$202
HARMONY BIOSCIENCES LLC
$65
CATALYST PHARMACEUTICALS, INC.
$17
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$946
Teva Pharmaceuticals USA, Inc.
$423
Supernus Pharmaceuticals, Inc.
$301
ABBVIE INC.
$249
GENZYME CORPORATION
$221
Sunovion Pharmaceuticals Inc.
$173
E.R. Squibb & Sons, L.L.C.
$160
UCB, Inc.
$149
Adamas Pharmaceuticals, Inc.
$123
Amgen Inc.
$121
Neurocrine Biosciences, Inc.
$104
Lundbeck LLC
$101
US WorldMeds, LLC
$88
Acorda Therapeutics, Inc
$84
ACADIA Pharmaceuticals Inc
$78
Novartis Pharmaceuticals Corporation
$78
HARMONY BIOSCIENCES LLC
$65
Lilly USA, LLC
$59
Janssen Pharmaceuticals, Inc
$54
Alexion Pharmaceuticals, Inc.
$46
Jazz Pharmaceuticals Inc.
$45
Mallinckrodt LLC
$36
AbbVie, Inc.
$33
EISAI INC.
$30
Avanir Pharmaceuticals, Inc.
$29
Upsher-Smith Laboratories LLC
$25
Allergan Inc.
$23
Genentech USA, Inc.
$22
Eisai Inc.
$22
GE HEALTHCARE
$20
CSL Behring
$19
Bayer HealthCare Pharmaceuticals Inc.
$19
CATALYST PHARMACEUTICALS, INC.
$17
Amneal Pharmaceuticals LLC
$14
Mitsubishi Tanabe Pharma America, Inc.
$13
Impax Laboratories, Inc.
$12
Top 3 companies account for 41.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BOTOX THERAPEUTIC · Betaseron · Briviact · COPAXONE · Duopa · EMGALITY · FYCOMPA · Fycompa · GILENYA · GOCOVRI · Hizentra · INBRIJA · INGREZZA · NAMZARIC · NORTHERA · NUEDEXTA · NUPLAZID · OCREVUS · ONFI · OXTELLAR XR · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RYTARY · Radicava · SOLIRIS · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · VUMERITY · WAKIX · XARELTO · Xadago · Xyrem · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurocritical care physicians within 10 mi
1
Per 100K population
0.5
County median income
$58,347
Nearest hospital
HEALTHSOURCE SAGINAW
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khan is a clinical cardiology specialist, with above-average Medicare volume (top 10% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with electromyography of arm or leg muscles?
Based on Medicare claims data, Dr. Khan performed 368 electromyography of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $4,002 from 36 companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other neurocritical care physicians in Saginaw?
Dr. Khan's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Neurocritical Care Physicians in Saginaw
Browse neurocritical care physicians in Saginaw ranked by procedure volume and transparency data.
Highest volume
Top Neurocritical Care Physicians in MI
Neurocritical care physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurocritical Care Physicians in MI
Which MI neurocritical care physicians receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology